{
    "low coverage regions": [
        "KLF1",
        "MAPK1"
    ],
    "genomic variants details": {
        "Somatic Variant Details - Potentially Actionable": [
            {
                "Gene": "KIT",
                "DNA Alteration": "c.1669T>A",
                "GeneMutation": "p.V559D Stopgain-LOF",
                "description": "KRAS is a GDP/GTP binding protein that acts as an intracellular signal transducer. KRAS is involved in several pathways involved in cellular proliferation and survival, including the PI3K-AKT-mTOR pathway and the Ras-Raf-MEK-ERK pathway. Activating mutations, copy number gains, and overexpression of KRAS are associated with cancer progression.",
                "VariantAlleleFraction": "25.44%"
            }
        ],
        "Somatic Variant Details - Biologically Relevant": [
            {
                "Gene": "BRAF",
                "DNA Alteration": "c.1397G>C",
                "GeneMutation": "p.K642E Frameshift-LOF",
                "description": "STK11 (LKB1) encodes an enzyme in the serine/threonine kinase family that is responsible for maintaining energy metabolism and cellular polarization through the activation of AMP-activated protein kinase and other members of the AMPK family. The enzyme also acts as a tumor suppressor by regulating cell growth. Loss of function mutations, copy number loss, epigenetic variation, and underexpression of STK11 are associated with cancer progression.",
                "VariantAlleleFraction": "10.63%"
            },
            {
                "Gene": "BRCA2",
                "DNA Alteration": "c.5946delT",
                "GeneMutation": "p.V600K Missensevariant(exon2)-GOF",
                "description": "FAT1 encodes a transmembrane protein involved in tumor suppressor signaling. FAT1 protein can regulate transcriptional activity by sequestering beta-catenin, thereby preventing it from entering the nucleus. Loss of function mutations and copy number loss of FAT1 are associated with cancer progression.",
                "VariantAlleleFraction": "28.01%"
            }
        ]
    },
    "clinical history": {
        "Date": "2024-03-25"
    },
    "other": {
        "ReportId": "3523",
        "ReportDate": "2024-03-29",
        "SignedBy": "William Martin",
        "Supervisor": "Dr. Sean Walton"
    }
}